US EditionPublished • loading... • Updated
Appeals court rejects NJ pharma challenges to Medicare drug pricing
Summary by NJBIZ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Appeals court rejects NJ pharma challenges to Medicare drug pricing
The basics: Third Circuit upholds lower court rulings against J&J, Bristol Myers, Novartis Program allows Medicare to negotiate drug prices under the IRA, saving seniors billions First round of negotiated prices starts 2026; discounts range 38%-79% on top drugs Pharma industry’s legal fight continues, Supreme Court last potential avenue A federal appeals court in Philadelphia rejected challenges by some of New Jersey’s biggest pharmaceutical co…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
